Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia? (Q94588786)
Jump to navigation
Jump to search
scientific article published on 05 May 2020
Language | Label | Description | Also known as |
---|---|---|---|
English | Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia? |
scientific article published on 05 May 2020 |
Statements
Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia? (English)
Spinello Antinori
Cecilia Bonazzetti
Guido Gubertini
Amedeo Capetti
Cristina Pagani
Valentina Morena
Sara Rimoldi
Laura Galimberti
Piercarlo Sarzi-Puttini
Anna Lisa Ridolfo